CLVS Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for CLVS is -3.98 -- better than just 3.15% of US stocks.
• As for revenue growth, note that CLVS's revenue has grown 56.59% over the past 12 months; that beats the revenue growth of 90.5% of US companies in our set.
• In terms of volatility of its share price, CLVS is more volatile than 97.12% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to Clovis Oncology Inc are EXK, GNTX, RMBS, SILC, and CTIC.
• Visit CLVS's SEC page to see the company's official filings. To visit the company's web site, go to www.clovisoncology.com.